New Elemental Impurities Tests for Pharmaceutical Products to Start in Less Than One Year. Are You ready?


  • European Broadcast: March 14, 2017: 9:00 a.m. EDT / 1:00 p.m. GMT / 2:00 p.m. CET
    US Broadcast: March 14, 2017: 11:00 a.m. EDT / 10:00 a.m. CDT / 8:00 a.m. PDT


March 14, 2017
  • Overview

    WEBINAR POSTPONED!

    Previous Date: March 14, 2017
    New Date: April 27, 2017

    The deadline for implementation of the new elemental impurities guidelines for drug products and ingredients is fast approaching. Implementation is scheduled for January 2018, by which time manufacturers of pharmaceutical drug products must comply with USP <232>/<233> and ICH Q3D.

    Recent harmonization between USP <232> and ICH Q3D, has resulted in complete alignment of the number of analytes and PDEs. In this webinar we will summarize the most recent updates.
    Read more
    Brought to you by:
    • Speakers

      Samina Hussain,
      Trace Metals Analysis,
      Department Manager,
      Health and Sciences Division of Exova Inc.
      Alexandra Taylor,
      Contributing Editor,
      C&EN